156 related articles for article (PubMed ID: 38154264)
21. International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.
Leach K; Hannan FM; Josephs TM; Keller AN; Møller TC; Ward DT; Kallay E; Mason RS; Thakker RV; Riccardi D; Conigrave AD; Bräuner-Osborne H
Pharmacol Rev; 2020 Jul; 72(3):558-604. PubMed ID: 32467152
[TBL] [Abstract][Full Text] [Related]
22. Personalised medicines for familial hypercalcemia and hyperparathyroidism.
Josephs TM; Zhang F; Dinh LV; Keller AN; Conigrave AD; Capuano B; Gregory KJ; Leach K
J Mol Endocrinol; 2022 May; 69(1):243-257. PubMed ID: 35318962
[TBL] [Abstract][Full Text] [Related]
23. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.
Nemeth EF; Shoback D
Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):373-84. PubMed ID: 23856266
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator].
Nagano N; Tsutsui T
Clin Calcium; 2016 Jun; 26(6):839-50. PubMed ID: 27230839
[TBL] [Abstract][Full Text] [Related]
25. Functional evaluation of a novel nonsense variant of the calcium-sensing receptor gene leading to hypocalcemia.
Saglia C; Arruga F; Scolari C; Kalantari S; Albanese S; Bracciamà V; Corso Faini A; Brach Del Prever G; Luca M; Romeo C; Mioli F; Migliorero M; Tessaris D; Carli D; Amoroso A; Vaisitti T; De Sanctis L; Deaglio S
Eur J Endocrinol; 2024 Mar; 190(4):296-306. PubMed ID: 38561929
[TBL] [Abstract][Full Text] [Related]
26. Allosteric modulation and G-protein selectivity of the Ca
He F; Wu CG; Gao Y; Rahman SN; Zaoralová M; Papasergi-Scott MM; Gu TJ; Robertson MJ; Seven AB; Li L; Mathiesen JM; Skiniotis G
Nature; 2024 Feb; 626(8001):1141-1148. PubMed ID: 38326620
[TBL] [Abstract][Full Text] [Related]
27. Rare diseases caused by abnormal calcium sensing and signalling.
Tőke J; Czirják G; Enyedi P; Tóth M
Endocrine; 2021 Mar; 71(3):611-617. PubMed ID: 33528764
[TBL] [Abstract][Full Text] [Related]
28. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain.
Petrel C; Kessler A; Dauban P; Dodd RH; Rognan D; Ruat M
J Biol Chem; 2004 Apr; 279(18):18990-7. PubMed ID: 14976203
[TBL] [Abstract][Full Text] [Related]
29. The calcium sensing receptor: from calcium sensing to signaling.
Zhang C; Miller CL; Brown EM; Yang JJ
Sci China Life Sci; 2015 Jan; 58(1):14-27. PubMed ID: 25576451
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia.
Lazarus S; Pretorius CJ; Khafagi F; Campion KL; Brennan SC; Conigrave AD; Brown EM; Ward DT
Eur J Endocrinol; 2011 Mar; 164(3):429-35. PubMed ID: 21135065
[TBL] [Abstract][Full Text] [Related]
31. Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia.
Cetani F; Lemmi M; Cervia D; Borsari S; Cianferotti L; Pardi E; Ambrogini E; Banti C; Brown EM; Bagnoli P; Pinchera A; Marcocci C
Eur J Endocrinol; 2009 Mar; 160(3):481-9. PubMed ID: 19073830
[TBL] [Abstract][Full Text] [Related]
32. GNA11 Variants Identified in Patients with Hypercalcemia or Hypocalcemia.
Howles SA; Gorvin CM; Cranston T; Rogers A; Gluck AK; Boon H; Gibson K; Rahman M; Root A; Nesbit MA; Hannan FM; Thakker RV
J Bone Miner Res; 2023 Jun; 38(6):907-917. PubMed ID: 36970776
[TBL] [Abstract][Full Text] [Related]
33. Novel mutations associated with inherited human calcium-sensing receptor disorders: A clinical genetic study.
García-Castaño A; Madariaga L; Pérez de Nanclares G; Ariceta G; Gaztambide S; Castaño L
Eur J Endocrinol; 2019 Jan; 180(1):59-70. PubMed ID: 30407919
[TBL] [Abstract][Full Text] [Related]
34. Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics.
Mayr B; Glaudo M; Schöfl C
Trends Endocrinol Metab; 2016 Sep; 27(9):643-652. PubMed ID: 27339034
[TBL] [Abstract][Full Text] [Related]
35. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
Grant MP; Stepanchick A; Breitwieser GE
Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
[TBL] [Abstract][Full Text] [Related]
36. Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1).
Dharmaraj P; Gorvin CM; Soni A; Nelhans ND; Olesen MK; Boon H; Cranston T; Thakker RV; Hannan FM
J Clin Endocrinol Metab; 2020 May; 105(5):1393-400. PubMed ID: 32150253
[TBL] [Abstract][Full Text] [Related]
37. Calcium-sensing receptor and associated diseases.
Hendy GN; Guarnieri V; Canaff L
Prog Mol Biol Transl Sci; 2009; 89():31-95. PubMed ID: 20374733
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
[TBL] [Abstract][Full Text] [Related]
39. Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.
Szalat A; Shahar M; Shpitzen S; Nachmias B; Munter G; Gillis D; Durst R; Mevorach D; Leitersdorf E; Meiner V; Rosen H
Endocrine; 2015 Mar; 48(2):444-53. PubMed ID: 25091521
[TBL] [Abstract][Full Text] [Related]
40. Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasis.
Livadariu E; Auriemma RS; Rydlewski C; Vandeva S; Hamoir E; Burlacu MC; Maweja S; Thonnard AS; Betea D; Vassart G; Daly AF; Beckers A
Eur J Endocrinol; 2011 Aug; 165(2):353-8. PubMed ID: 21566074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
